Clinical trial
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
NCT00537901 is registered in ClinicalTrials.gov with King Faisal Specialist Hospital & Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
- Lead sponsor
- King Faisal Specialist Hospital & Research Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- October 31, 2013
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.